BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7123575)

  • 21. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
    Pasich J; Drobnicka B; Kasprzyk A
    Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergy to aminophylline: lack of predictability by skin testing.
    Kradjan WA; Lakshminarayan S
    Am J Hosp Pharm; 1981 Jul; 38(7):1031-3. PubMed ID: 7258203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theophylline-glycinate suppositories: a potentially more stable source of theophylline than aminophylline suppositories B.P. [proceedings].
    Pryce-Jones RH; Watt D; Kraisintu K
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():52P. PubMed ID: 42728
    [No Abstract]   [Full Text] [Related]  

  • 24. Preparation of progesterone suppositories.
    Roffe BD; Zimmer RA; Derewicz HJ
    Am J Hosp Pharm; 1977 Dec; 34(12):1344-6. PubMed ID: 596385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preformulation experiences and in vitro model studies with spironolactone-containing suppositories.
    Regdon G; Deák D; Regdon G; Muskó Z; Erös I
    Pharmazie; 2001 Jan; 56(1):70-3. PubMed ID: 11213791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of aminophylline and promethazine in suppositories by high-performance liquid chromatography.
    Kountourellis JE; Raptouli A; Georgarakis M
    Pharmazie; 1986 Aug; 41(8):600-1. PubMed ID: 3786388
    [No Abstract]   [Full Text] [Related]  

  • 27. Formulation effects on the mechanical and release properties of metronidazole suppositories.
    Adegboye TA; Itiola OA
    Afr J Med Med Sci; 2003 Sep; 32(3):247-51. PubMed ID: 15030082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketorolac tromethamine and ketoprofen suppositories: release profiles and bioavailability of a cocoa butter base formula in rabbits.
    Zia H; Rashed SF; Quadir M; Needham TE; Squillante E
    Int J Pharm Compd; 1998; 2(5):390-3. PubMed ID: 23989705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug stability in lyophilic suppository media].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(2):257-8. PubMed ID: 4840677
    [No Abstract]   [Full Text] [Related]  

  • 30. Study on stability of drugs in lyophilic suppository bases. 3. Isolation of cyclovegantine, ethionamide and euphyllin degradation products from suppositories.
    Cieszyński T
    Acta Pol Pharm; 1972; 29(1):75-83. PubMed ID: 5055291
    [No Abstract]   [Full Text] [Related]  

  • 31. [Production technology and in vitro study of rectal suppositories containing chloroquine phosphate].
    Regdon Géza JR; Schirm I; Pittmann A; Regdon G
    Acta Pharm Hung; 1995 Mar; 65(2):45-50. PubMed ID: 7793289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of cefuroxime sodium and aminophylline or theophylline.
    Stewart JT; Warren FW; Johnson SM
    Am J Hosp Pharm; 1994 Mar; 51(6):809-11. PubMed ID: 8010322
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmaceutical studies on and clinical application of olanzapine suppositories prepared as a hospital preparation.
    Matsumoto K; Kimura S; Takahashi K; Yokoyama Y; Miyazawa M; Kushibiki S; Katamachi M; Kizu J
    J Pharm Health Care Sci; 2016; 2():20. PubMed ID: 27672443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preformulation studies on suppositories by thermal methods.
    Giordano F; La Manna A; Bettinetti GP; Zamparutti M
    Boll Chim Farm; 1990 Apr; 129(4):160-5. PubMed ID: 2245004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in the pharmaceutical and biological availability of aminophylline from suppositories containing non-ionogenic surface-active agents after a year of storage].
    Bartkowicz S; Pawlik T; Krówczyński L; Gudowska T; Gacek M
    Acta Pol Pharm; 1985; 42(2):165-71. PubMed ID: 4083053
    [No Abstract]   [Full Text] [Related]  

  • 36. Preparation of spherically agglomerated crystals of aminophylline.
    Kawashima Y; Aoki S; Takenaka H; Miyake Y
    J Pharm Sci; 1984 Oct; 73(10):1407-10. PubMed ID: 6502490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physicopharmaceutical characteristics of ulinastatin vaginal suppositories prepared in a hospital].
    Satake K; Nakajima T; Iwata M; Fujikake Y; Kimura M
    Yakugaku Zasshi; 2011; 131(11):1639-44. PubMed ID: 22041703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anal suppositories containing antiphlogistic and analgesic substances. III. Stability of anal suppositories containing mefenamic acid prepared on selected hydrophobic bases].
    Kosior A
    Ann Univ Mariae Curie Sklodowska Med; 1985; 40():203-8. PubMed ID: 3917082
    [No Abstract]   [Full Text] [Related]  

  • 39. Stability and compatibility of fluconazole and aminophylline in intravenous admixtures.
    Johnson CE; Jacobson PA; Pillen HA; Woycik CL
    Am J Hosp Pharm; 1993 Apr; 50(4):703-6. PubMed ID: 8470689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminolevulinic acid-loaded Witepsol microparticles manufactured using a spray congealing procedure: implications for topical photodynamic therapy.
    Al-Kassas R; Donnelly RF; McCarron PA
    J Pharm Pharmacol; 2009 Sep; 61(9):1125-35. PubMed ID: 19703361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.